Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits

Clinical Science

Volumn 104, Issue 4, 2003, Pages 357-365

  De Las Heras, Natalia ^a   Cediel, Eva ^a   Oubiña, M Pilar ^a   Aragoncillo, Paloma ^b   Sanz Rosa, David ^a   Lahera, Vicente ^a   Cachofeiro, Victoria ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Endothelial function; Fibrinolytic balance; Hypercholesterolaemia; Intimal thickening; Mixed dyslipidaemia

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; CHOLESTEROL; COCONUT OIL; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; IFETROBAN; N(G) NITROARGININE METHYL ESTER; PD 145; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN H2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; DYSLIPIDEMIA; ENDOTHELIUM; FIBRINOLYSIS; HORMONE ACTION; HYPERCHOLESTEROLEMIA; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR RING; VASOCONSTRICTION;

ACETYLCHOLINE; ANIMALS; AORTA; ARTERIOSCLEROSIS; BICYCLO COMPOUNDS, HETEROCYCLIC; DIET; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FIBRINOLYSIS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; MALE; MODELS, ANIMAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OXAZOLES; PLASMINOGEN ACTIVATOR INHIBITOR 1; RABBITS; THROMBOXANE A2; TISSUE PLASMINOGEN ACTIVATOR; VASOCONSTRICTOR AGENTS;

EID: 0037391214     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20020199     Document Type: Article

References (34)

1. Jayakody, L., Senaratne, M., Thompson, A. and Kappagoda, T. (1987) Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ. Res. 60, 251-264
2. Zeiher, A. M., Drexler, H., Wollschläger, H. and Just, H. (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83, 391-401
3. Chowienezyk, P. J., Watts, G. F., Cockcroft, J. R. and Ritter, J. M. (1992) Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet 340, 1430-1432
4. de las Heras, N., Aragoncilio, P., Maeso, R. et al. (1999) AT1 receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits. Hypertension 34, 969-975
5. Dart, A. M. and Chin Dusting, J. P. (1999) Lipids and the endothelium. Cardiovasc. Res. 43, 308-322
6. Berliner, J. A., Navab, M., Fogelman, A. M. et al. (1995) Atherosclerosis: basic mechanisms. Oxidation, inflammation and genetics. Circulation 91, 2488-2496
7. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London) 262, 801-809
8. Oubiña, M. P., de las Heras, N., Vázquez-Pérez, S. et al. (2002) Valsartan improves fibrinolytic balance in atherosclerotic rabbits. J. Hypertens. 20, 303-310
9. Geppert, A., Graf, S., Beckman, R. et al. (1998) Concentration of endogenous tPA antigen in coronary artery disease: Relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. Arterioscler., Thromb., Vasc. Biol. 18, 1634-1642
10. de Man, F. H., Weverling Rijnsburger, A. W., van der Laarse, A., Smelt, A. H., Jukema, J. W. and Blauw, G. J. (2000) Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arterioscler., Thromb., Vasc. Biol. 20, 744-750
11. Torok, J., Babal, P., Matuskova, J., Luptak, I., Klimes, I. and Simko, F. (2002) Impaired endothelial function of thoracic aorta in hereditary hypertriglyceridemic rats. Ann. N.Y. Acad. Sci. 967, 469-475
12. Salomaa, V., Riley, W., Kark, J. D., Nardo, C. and Folsam, A. R. (1995) Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 91, 1432-1443
13. Ushiroyama, T., Ikeda, A., Higashio, S. and Ueki, M. (2000) Coagulofibrinolytic assessment effects of bezafibrate on hypertriglyceridemia in postmenopausal women. Blood Coagulation Fibrinolysis 11, 709-711
14. Seligman, B. G. S., Biolo, A., Polanczyk, C. A., Gross, J. L. and Clausell, N. (2000) Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. Diabetes Care 23, 1395-1400
15. Davi, G., Averna, M., Catalano, I. et al. (1992) Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation 85, 1792-1798
16. Aragoncillo, P., Maeso, R., Vázquez-Pérez, S. et al. (2000) The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbits. Virchows Archiv. 437, 545-554
17. Bonthu, S., Heistad, D. D., Chappell, D., Lamping, K. G. and Faraci, F. M. (1997) Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler., Thromb., Vasc. Biol. 17, 2333-2340
18. Dowell, F. J., Hamilton, C. A., Lindop, G. B. M. and Reid, J. L. (1995) Development and progression of atherosclerosis in aorta from heterozygous and homozygous WHHL rabbits. Effect of simvastatin treatment. Arterioscler., Thromb., Vasc. Biol. 15, 1152-1160
19. Räisänen Sokolowski, A., Tilly Kiesi, M., Ustinov, J. et al. (1994) Hyperlipidemia accelerates allograft arteriosclerosis (chronic rejection) in the rat. Arterioscler., Thromb., Vasc. Biol. 14, 2032-2042
20. Hennig, B., Hong Chung, B., Watkins, B. A. and Alvarado, A. (1992) Disruption of endothelial barrier function by lipolytic remnants of triglyceride-rich lipoproteins. Atherosclerosis (Shannon, Irel.) 95, 235-247
21. Yu, K. C. W. and Cooper, A. D. (2001) Postpandrial lipoproteins and atherosclerosis. Front. Biosci. 6, D332-D354
22. Lundman, P., Eriksson, M. J., Stuhlinger, M., Cooke, J. P., Hamsten, A. and Tornvall, P. (2001) Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J. Am. Coll. Cardiol. 38, 111-116
23. Chowienczyk, P. J., Watts, G. F., Wierzbicki, A. S., Cockcroft, J. R., Brett, S. E. and Ritter, J. M. (1997) Preserved endothelial functional in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. J. Am. Coll. Cardiol. 29, 964-968
24. Jonkers, I. J., van de Ree, M. A., Smelt, A. H. et al. (2002) Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hvpertriglyceridemia. Cardiovasc. Res. 53, 496-501
25. Vakkilainen, J., Mákimattila, S., Seppälä-Lindroos, A. et al. (2000) Endothelial dysfunction in men with small LDL particles. Circulation 102, 716-721
26. Toutouzas, P. C., Tousoulis, D. and Davies, G. J. (1998) Nitric oxide synthesis in atherosclerosis. Eur. Heart J. 19, 1504-1511
27. Arnal, J. F., Dinh-Xuan, A. T., Pueyo, M., Darblade, B. and Rami, J. (1999) Endothelium-derived nitric oxide and vascular physiology and pathology. Cell. Mol. Life Sci. 55, 1078-1087
28. Hernández-Perera, O., Pérez-Sala, D., Navarro-Antolín, J. et al. (1998) Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J. Clin. Invest. 101, 2711-2719
29. Vergnani, L., Hatrik, S., Ricci, F. et al. (2000) Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of L-arginine availability. Circulation 101, 1261-1266
30. Husain, S., Andrews, P., Mulcahy, D., Panza, J. A. and Quyyumi, A. A. (1998) Aspirin improves endothelial dysfunction in athersoclerosis. Circulation 97, 716-720
31. Bank, N. and Aynedjian, H. S. (1992) Role of thromboxane in impaired renal vasodilatation response to acetylcholine in hypercholesterolemic rats. J. Clin. Invest. 89, 1636-1642
32. Evans, M., Anderson, R. A., Graham, J. et al. (2000) Ciprofibrate therapy improves endothelial function and reduces postpandrial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation 101, 1773-1776
33. Eriksson, P., Nilsson, L., Karpe, F. and Hamsten, A. (1998) Very-low density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis in hypertriglyceridemia. Arterioscler., Thromb., Vasc. Biol. 18, 20-26
34. Grafe, M., Auch-Schwelk, W., Hertel, H. et al. (1998) Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. Atherosclerosis (Shannon, Irel.) 137, 87-95